Brent Constantz Ph.D.

Corazon, Inc.
Menlo Park, CA

Brent Constantz is interested in biomineralization and the design of mineralized structures and their function. He has investigated skeletogenetic processes in every animal phylum. Most of his work has been on reef building corals and mammalian bone. Recently he has become interested in pathological calcification of the cardiovascular system. In the orthopaedic medical device area, he formed Norian Corporation in 1987, a pioneer in synthetic bone cement for bone fixation and replacement. He served as President & Chief Executive Officer at Norian, now a subsidiary of Synthes Inc., until coming to Stanford as a Visiting Scholar in 1998. Now a Consulting Associate Professor teaching biomineralization in the Biomechanical Engineering Division, Dr. Constantz formed his second medical device company, Corazon Technologies, Inc., in 1999 where he currently serves as President & Chief Executive Officer. Corazon is a cardiovascular device company based in Palo Alto addressing pathological calcification of the cardiovascular sysytem. Dr. Constantz received a doctorate in Earth Sciences at the University of California at Santa Cruz in 1986 and was a Fulbright Scholar the Weizmann Institute of Science studying biomineralization in 1986-1987.